Condition
Psychosis Not Otherwise Specified (NOS)
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting1
Terminated1
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07703670Not ApplicableRecruiting
MicroRNAs as Biomarkers in First Episode Schizophrenia
NCT01624831Terminated
Social Cognition in Longstanding Psychosis
NCT02661347Not ApplicableWithdrawn
Transcranial Direct Current Stimulation for Hallucinations in First-Episode Schizophrenia
Showing all 3 trials